EUVIMEDEUVIMED entdecken
Open Access

SIRT6 mitigates doxorubicin-induced cardiomyopathy via amelioration of mitochondrial dysfunction: A mechanistic study implicating the activation of the Nrf-2/FUNDC1 signaling axis

Qi Wang, Hongshuo Shi, Haowen Zhuang, Guangtong Dong, Kuo Gao, Leilei Liu, Hao Zhou, Yifeng Nie, Junyan Wang, Li Liu

International Journal of Medical Sciences · 2025

DOI: 10.7150/ijms.101520 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Qi Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150040, China. Hauptthemen laut MEDLINE: Doxorubicin, Sirtuins, Cardiomyopathies, Mitochondrial Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinSirtuinsCardiomyopathiesMitochondrial ProteinsAnimalsSignal TransductionNF-E2-Related Factor 2HumansMyocytes, CardiacMiceApoptosisRatsMaleMitochondria, HeartMitochondriaDisease Models, Animal

Stichwörter der Autor:innen

Nrf-2SIRT6doxorubicin cardiomyopathymitochondrial biogenesisnecroptosis

Substanzen

DoxorubicinSirtuinsNF-E2-Related Factor 2Mitochondrial ProteinsSirt6 protein, mouseNfe2l2 protein, mouse

Autor:innen und Institutionen

  • First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
  • Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong,510006, China.
  • Beijing University of Chinese Medicine, Beijing, 100105, China.
  • University of Rochester Medical Center Rochester, NY, 601 Elmwood Ave, Rochester, NY 14642, United States.
  • CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, P.R China.

Zitieren

APA

Wang, Q., Shi, H., Zhuang, H., Dong, G., Gao, K., Liu, L., Zhou, H., Nie, Y., Wang, J., & Liu, L. (2025). SIRT6 mitigates doxorubicin-induced cardiomyopathy via amelioration of mitochondrial dysfunction: A mechanistic study implicating the activation of the Nrf-2/FUNDC1 signaling axis. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.101520

Vancouver

Wang Q, Shi H, Zhuang H, Dong G, Gao K, Liu L, et al. SIRT6 mitigates doxorubicin-induced cardiomyopathy via amelioration of mitochondrial dysfunction: A mechanistic study implicating the activation of the Nrf-2/FUNDC1 signaling axis. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.101520

BibTeX
@article{Wang2025,
  author = {Wang, Qi and Shi, Hongshuo and Zhuang, Haowen and Dong, Guangtong and Gao, Kuo and Liu, Leilei and Zhou, Hao and Nie, Yifeng and Wang, Junyan and Liu, Li},
  title = {SIRT6 mitigates doxorubicin-induced cardiomyopathy via amelioration of mitochondrial dysfunction: A mechanistic study implicating the activation of the Nrf-2/FUNDC1 signaling axis},
  journal = {International Journal of Medical Sciences},
  year = {2025},
  doi = {10.7150/ijms.101520}
}
Kostenlos starten →